Startups
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. Our proprietary drugs offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
Overview
Location
United States, Minnesota, Plymouth
Employees
1-10
Total raised
$7M
Founded date
2012
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Mar 27, 2017 | Grant | $2M |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Three “hits” on biopharma market trends at mcINVEST | Day one of MedCity INVEST, an annual healthcare investment conference held in Chicago, highlighted different facets of today’s biopharma industry — from startups to VCs to Big Pharma partnerships. It began with a panel discussion on hot inv... |
Reviews 0
FAQ about SpineThera
When was SpineThera founded?
SpineThera was founded in 2012.
How much funding has SpineThera raised?
SpineThera has raised $7M in total across 2 funding rounds.
What funding rounds has SpineThera raised?
Parsers VC lists 2 funding rounds of SpineThera, among them a grant of $2M on Mar 27, 2017.
What has the press written about SpineThera?
Parsers VC has collected 2 articles mentioning SpineThera, among them “Three “hits” on biopharma market trends at mcINVEST”.
Is SpineThera still active?
Yes, SpineThera is active; its latest activity on Parsers VC dates from May 18, 2017.